Core Viewpoint - Tianan Health (00383.HK) announced a share buyback of 75,000 shares at a cost of HKD 75,000 on November 17 [1] Summary by Category - **Company Actions** - The company executed a buyback of 75,000 shares, indicating a commitment to enhancing shareholder value [1]

Group 1 - The company Tianan Health (00383) announced a share buyback plan [1] - The total amount allocated for the buyback is HKD 75,000 [1] - The company plans to repurchase 75,000 shares at a price of HKD 1 per share [1]

FF305 翌日披露報表 (股份發行人 ── 已發行股份或庫存股份變動、股份購回及/或在場内出售庫存股份) 表格類別： 股票 狀態： 新提交 公司名稱： 天安卓健有限公司 呈交日期： 2025年11月17日 如上市發行人的已發行股份或庫存股份出現變動而須根據《香港聯合交易所有限公司（「香港聯交所」）證券上市規則》(「《主板上市規則》」)第13.25A條 / 《香港聯合交易所有限公司GEM證券 上市規則》(「《GEM上市規則》」)第17.27A條作出披露，必須填妥第一章節 。 | 第一章節 | | | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | 於香港聯交所上市 | 是 | | | 證券代號 (如上市) | 00383 | 說明 | | | | | | | A. 已發行股份或庫存股份變動 | | | | | | | | | | | 已發行股份（不包括庫存股份）變動 | | | 庫存股份變動 | | | | | 事件 | 已發行股份（不包括庫存股份）數 目 | | 佔有關事 ...

Core Viewpoint - Tianan Health (00383) has announced a renovation agreement for the second phase of Kunming Tongren Hospital, with a total cost of RMB 130 million [1] Group 1: Agreement Details - The renovation agreement is between Kunming Tongren Hospital Co., Ltd. and Zhejiang ShunJie Construction Group Co., Ltd. [1] - The scope of the renovation includes the Thyroid Center, Comprehensive Inpatient Building, and Rehabilitation Medicine Building, covering a total construction area of approximately 48,357 square meters [1] Group 2: Management's Perspective - The board believes that the transaction under the renovation agreement is conducted on normal commercial terms [1] - The terms of the renovation agreement are considered fair and reasonable [1] - Entering into the renovation agreement is in the overall interest of the company and its shareholders [1]

Core Viewpoint - Tianan Health (00383.HK) announced a renovation agreement for the second phase of Kunming Tongren Hospital, with a contract value of RMB 129.8 million, to be executed by Zhejiang Shunjie Construction [1] Group 1: Project Details - The renovation agreement includes the decoration and renovation of the Thyroid Center, Comprehensive Inpatient Building, and Rehabilitation Medicine Building [1] - Zhejiang Shunjie Construction has been the general contractor for the civil engineering of the second phase of Kunming Tongren Hospital, and the collaboration has been satisfactory [1] Group 2: Strategic Importance - The selection of the contractor for the renovation work aims to ensure a smooth continuation of the project following the completion of the civil engineering phase [1]

Core Viewpoint - Tianan Health (00383) announced a renovation agreement for the second phase of Kunming Tongren Hospital, with a total cost of RMB 130 million [1] Group 1: Agreement Details - The renovation agreement is between Kunming Tongren Hospital Co., Ltd. and Zhejiang ShunJie Construction Group Co., Ltd. [1] - The scope of the renovation includes the Thyroid Center, Comprehensive Inpatient Building, and Rehabilitation Medicine Building, covering a total construction area of approximately 48,357 square meters [1] Group 2: Management's Perspective - The board believes that the transaction under the renovation agreement is conducted on normal commercial terms [1] - The terms of the renovation agreement are considered fair and reasonable by the board [1] - Entering into the renovation agreement is deemed to be in the overall interest of the company and its shareholders [1]

裝修工程協議 董事會謹此宣佈，於二零二五年十一月十三日（交易時段後），委託方（本公司之間 接全資擁有附屬公司）與承建商就昆明同仁醫院二期之裝修工程（包括（其中包括） 甲狀腺中心、綜合住院樓及康復醫學樓的裝飾及裝修工程）訂立裝修工程協議，代 價為人民幣129,834,285.77元（相當於約142,025,725.20港元）。 上市規則之涵義 由於裝修工程協議項下擬進行之交易有關之其中一項適用之百分比率（定義見上 市規則）超過5%但所有適用百分比率均低於25%，該交易構成本公司之一項須予 披露交易，因此須遵守上市規則第14章項下之申報及公告規定。 香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責，對其準確性或完 整性亦不發表任何聲明，並明確表示，概不對因本公告全部或任何部份內容而產生或因倚賴該等內 容而引致之任何損失承擔任何責任。 MEDICARE （於百慕達註冊成立之有限公司） （股份代號：383） 須予披露交易 有關昆明同仁醫院二期之裝修工程協議 1 緒言 董事會謹此宣佈，於二零二五年十一月十三日（交易時段後），委託方（本公司之間接 全資擁有附屬公司）與承建商就昆明同仁醫院二期之裝修工 ...

Core Viewpoint - Tianan Health (00383.HK) announced a share buyback plan to repurchase 5,000 shares at a price of HKD 1 per share on November 12, 2025, totaling HKD 5,000 [1] Summary by Category - **Company Announcement** - Tianan Health plans to buy back 5,000 shares at a price of HKD 1 each [1] - The total amount for the buyback will be HKD 5,000 [1] - **Financial Implications** - The buyback indicates the company's strategy to enhance shareholder value [1] - The repurchase price reflects the company's current valuation and market conditions [1]

Core Viewpoint - Tianan Health (00383) announced a share buyback plan, intending to repurchase 5,000 shares at a total cost of HKD 5,000, with each share priced at HKD 1 [1] Summary by Category - **Company Actions** - The company will repurchase 5,000 shares, indicating a commitment to returning value to shareholders [1] - The buyback price is set at HKD 1 per share, reflecting the company's valuation strategy [1] - **Financial Implications** - The total expenditure for the buyback is HKD 5,000, which may impact the company's cash reserves [1]

Core Viewpoint - Tianan Health (00383) announced a share buyback plan, intending to repurchase 5,000 shares at a total cost of 5,000 HKD, with each share priced at 1 HKD [1] Summary by Category - **Company Actions** - The company will execute a share buyback on November 12, 2025, spending a total of 5,000 HKD to buy back 5,000 shares [1]